Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
Superinvestors holding ENLV, Q2 2026
1 superinvestor reports holding Enlivex Ltd. on Form 13F, worth $1.31M in total. Weight is Enlivex Ltd.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| ARK InvestCathie Wood | <0.1% | 2,382,731 | $1.31M | Added+279.2% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ENLV each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- Added
- ARK Invest (+279.2%)
Q1 2026
1 superinvestor holding at quarter end
- New
- ARK Invest
Q3 2022
0 superinvestors holding at quarter end
- Sold out
- ARK Invest
Q2 2022
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−23.8%)
Q1 2022
1 superinvestor holding at quarter end
- Added
- ARK Invest (+24.3%)
Q4 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−23.7%)
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−11.1%)
Q2 2021
1 superinvestor holding at quarter end
- Added
- ARK Invest (+8.1%)